Suven Life Sciences informs about board meeting procedures

09 Aug 2021 Evaluate
Suven Life Sciences has informed that the Board of Directors of the company, at its meeting held today 09th August, 2021, has taken on record and approved the Un-audited Standalone and Consolidated Financial Results of the Company under Ind AS along with review reports of the Statutory Auditors for the quarter ended 30th June, 2021. It has enclosed the following documents:; un-audited Standalone and Consolidated Financial Results under Ind AS for the quarter ended 09th August, 2021; Limited Review Reports of Statutory Auditors of the Company on the financial results as mentioned above and A copy of the News Release of the company. Update on patents during this period can be viewed at: http://suven.com/Patentupdates.aspx. The Board Meeting commenced at 11:30 A.M. and concluded at 12:30 PM.

The above information is a part of company’s filings submitted to BSE.

Suven Life Sciences Share Price

166.05 -1.75 (-1.04%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×